Evidence map›Paper›PMID 37788673›Full record

ArticleMolecular cell2023

ATR promotes clearance of damaged DNA and damaged cells by rupturing micronuclei.

Yoon Ki Joo, Elizabeth M Black, Isabelle Trier, Wisse Haakma, Lee Zou, Lilian Kabeche

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. DONSON links tumor-cell survival to MIF-associated macrophage remodeling in small cell lung cancer.Apoptosis : an international journal on programmed cell death · 2026
    Article
  3. Autophagy modulation in cancer.Nature reviews. Drug discovery · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Chromosomal Instability Drives Glioblastoma Heterogeneity and Therapeutic Opportunities.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yoon Ki JooDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA; Yale Cancer Biology Institute, Yale University, New Haven, CT 06516, USA.
Elizabeth M BlackDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA; Yale Cancer Biology Institute, Yale University, New Haven, CT 06516, USA.
Isabelle TrierDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA; Yale Cancer Biology Institute, Yale University, New Haven, CT 06516, USA.
Wisse HaakmaMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Boston, MA 02129, USA.
Lee ZouMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Boston, MA 02129, USA; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27708, USA. Electronic address: lee.zou@duke.edu.
Lilian KabecheDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA; Yale Cancer Biology Institute, Yale University, New Haven, CT 06516, USA. Electronic address: lilian.kabeche@yale.edu.
Yale Cancer Center · USHarvard University · US

Funding

Understanding and targeting the DNA replication stress in cancer cellsR35CA263934 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Lee Zou · 2021 to 2026
$5.2M
Implications of the ATR Checkpoint Kinase in Radiation and Targeted TherapiesR01CA197779 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI ZOU, LEE · 2015 to 2020
$2.4M
Elucidating how ATR promotes genome stability independent of the DNA damage response pathwayR35GM150648 · NIGMS · YALE UNIVERSITY · PI Lilian Carolina Kabeche · 2023 to 2026
$1.7M
Impacts of APOBECs on DNA replication, ATR checkpoint, and cancer therapyR01CA218856 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI ZOU, LEE · 2018 to 2021
$1.5M
Defining the DNA damage pathway in faithful mitotic progressionK22CA244865 · NCI · YALE UNIVERSITY · PI KABECHE, LILIAN CAROLINA · 2020 to 2022
$559k
Defining the Mitotic Role of Chk2 for the Treatment of Pancreatic CancerF31CA275096 · NCI · YALE UNIVERSITY · PI BLACK, ELIZABETH MAUREEN · 2023 to 2024
$69k
NCI NIH HHS F31 CA275096NCI NIH HHS K22 CA244865NCI NIH HHS R01 CA197779NCI NIH HHS R01 CA218856NCI NIH HHS R35 CA263934NIGMS NIH HHS R35 GM150648
6 · The paper itself

Abstract

The human ataxia telangiectasia mutated and Rad3-related (ATR) kinase functions in the nucleus to protect genomic integrity. Micronuclei (MN) arise from genomic and chromosomal instability and cause aneuploidy and chromothripsis, but how MN are removed is poorly understood. Here, we show that ATR is active in MN and promotes their rupture in S phase by phosphorylating Lamin A/C at Ser395, which primes Ser392 for CDK1 phosphorylation and destabilizes the MN envelope. In cells harboring MN, ATR or CDK1 inhibition reduces MN rupture. Consequently, ATR inhibitor (ATRi) diminishes activation of the cytoplasmic DNA sensor cGAS and compromises cGAS-dependent autophagosome accumulation in MN and clearance of micronuclear DNA. Furthermore, ATRi reduces cGAS-mediated senescence and killing of MN-bearing cancer cells by natural killer cells. Thus, in addition to the canonical ATR signaling pathway, an ATR-CDK1-Lamin A/C axis promotes MN rupture to clear damaged DNA and cells, protecting the genome in cell populations through unexpected cell-autonomous and cell-non-autonomous mechanisms.

Indexed as

DNA DamageLamin Type AAtaxia Telangiectasia Mutated ProteinsDNAHumansNucleotidyltransferasesPhosphorylationAtaxia Telangiectasia Mutated ProteinsATR protein, humanDNALamin Type ANucleotidyltransferasesATRautophagosomeautophagyCDK1cell-autonomouscell-non-autonomouscGASclearancedamaged DNADNA damagemicronuclear DNAmicronucleimicronucleusnatural killer cellsnuclear enveloperuptureSTINGTREX1

Identifiers

PMID37788673
PMCPMC10599252
OpenAlexW4387252947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.